阿斯利康（NASDAQ:AZN）報告其季度每股收益爲 $1.04，超出分析師一致預期的 $1.03，增幅爲 1.46%。與去年同期的每股收益 $0.72 相比，增長了 44.14%。該公司報告的季度銷售額爲 $148.91 億美元，超出分析師一致預期的 $142.92 億美元，增幅爲 4.19%。與去年同期的銷售額 $120.24 億美元相比，增長了 23.84%。

以上內容來自Benzinga Earnings專欄，原文如下：

AstraZeneca (NASDAQ:AZN) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.03 by 1.46 percent. This is a 44.14 percent increase over earnings of $0.72 per share from the same period last year. The company reported quarterly sales of $14.891 billion which beat the analyst consensus estimate of $14.292 billion by 4.19 percent. This is a 23.84 percent increase over sales of $12.024 billion the same period last year.